FIELD: medicine.
SUBSTANCE: means has micro-particles of practically pure active substance immersed into biologically compatible pharmacologically permissible polymer. The polymer is ester of polyol and copolymer of polylactide and glycolide. The polyol has at least three hydroxide groups and molecular weight not greater than 20000.
EFFECT: enhanced effectiveness in introducing drug as depot; supporting therapeutically effective dose of active substance.
9 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| ACTIVE DRUG DELIVERY TO DISTANT EYE REGION BY SUBCONJUNCTIVAL OR PERIOCULAR PRODRUG DELIVERY | 2004 |
|
RU2353393C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| LOCAL EYE PEPTIDE COMPOSITION | 2010 |
|
RU2561585C2 |
| PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS FOR THEIR PRODUCTION AND USE | 2013 |
|
RU2789479C2 |
| OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITIONS FOR NEOANGIOGENIC EYE PATHOLOGIES | 2009 |
|
RU2519739C2 |
| PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF | 2013 |
|
RU2663117C2 |
| IMPLANT FOR PROLONGED DRUG DELIVERY | 2014 |
|
RU2641021C2 |
| ASCOMYCIN-CONTAINING OPHTHALMIC COMPOSITION | 2002 |
|
RU2313344C2 |
